These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 14579916)

  • 1. Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease.
    Lu TM; Ding YA; Charng MJ; Lin SJ
    Clin Cardiol; 2003 Oct; 26(10):458-64. PubMed ID: 14579916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between plasma asymmetrical dimethylarginine and coronary artery disease].
    Song Y; Qu XF; Yu YW; Luan TZ; Li JJ; Guo H; Yu Y
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1527-30. PubMed ID: 17785101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study.
    Kruszelnicka O; Surdacki A; Golay A
    Cardiovasc Diabetol; 2013 Oct; 12():145. PubMed ID: 24103320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of asymmetric dimethylarginine (ADMA) with extent and functional severity of coronary atherosclerosis.
    Mangiacapra F; Conte M; Demartini C; Muller O; Delrue L; Dierickx K; Di Sciascio G; Trimarco B; De Bruyne B; Wijns W; Bartunek J; Barbato E
    Int J Cardiol; 2016 Oct; 220():629-33. PubMed ID: 27391005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of plasma asymmetric dimethylarginine (ADMA) level and L-arginine/ADMA ratio on the development of coronary collaterals].
    Selçuk MT; Selçuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Duru E; Saşmaz A
    Turk Kardiyol Dern Ars; 2008 Apr; 36(3):150-5. PubMed ID: 18626206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography.
    Lu TM; Chung MY; Lin MW; Hsu CP; Lin SJ
    Int J Cardiol; 2011 Dec; 153(2):135-40. PubMed ID: 21794936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma asymmetric dimethylarginine level and extent of lesion at coronary angiography.
    Sahinarslan A; Cengel A; Biberoglu G; Hasanoglu A; Turkoglu S; Timurkaynak T
    Coron Artery Dis; 2006 Nov; 17(7):605-9. PubMed ID: 17047444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of asymmetrical dimethylarginine (ADMA) and coronary artery disease in men with erectile dysfunction.
    Maas R; Wenske S; Zabel M; Ventura R; Schwedhelm E; Steenpass A; Klemm H; Noldus J; Böger RH
    Eur Urol; 2005 Dec; 48(6):1004-11; discussion 1011-2. PubMed ID: 16139418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethylarginine and coronary collateral vessel development.
    Kocaman SA; Sahinarslan A; Biberoglu G; Hasanoglu A; Akyel A; Timurkaynak T; Cengel A
    Coron Artery Dis; 2008 Nov; 19(7):469-74. PubMed ID: 18923242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of asymmetric dimethylarginine levels with treadmill-stress-test-derived prognosticators.
    Deftereos S; Bouras G; Tsounis D; Papadimitriou C; Hatzis G; Raisakis K; Panagopoulou V; Kaoukis A; Ioannidis A; Deftereos G; Kossyvakis C; Manolis AS; Alexopoulos D; Stefanadis C; Cleman MW; Giannopoulos G
    Clin Biochem; 2014 May; 47(7-8):593-8. PubMed ID: 24525256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the relationship between asymmetric dimethylarginine and severity of erectile dysfunction and coronary artery disease.
    Aktoz T; Aktoz M; Tatlı E; Kaplan M; Turan FN; Barutcu A; Atakan IH; Demir M; Altun A
    Int Urol Nephrol; 2010 Dec; 42(4):873-9. PubMed ID: 20091222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between Dietary Approaches to Stop Hypertension score and Alternative Healthy Eating Index score with plasma asymmetrical dimethylarginine levels in patients referring for coronary angiography.
    Mokhtari Z; Hosseini S; Miri R; Baghestani AR; Zahedirad M; Rismanchi M; Nasrollahzadeh J
    J Hum Nutr Diet; 2015 Aug; 28(4):350-6. PubMed ID: 25786774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
    Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
    Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
    Wang Z; Tang WH; Cho L; Brennan DM; Hazen SL
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1383-91. PubMed ID: 19542023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma asymmetric dimethylarginine and L-arginine levels in patients with cardiac syndrome X.
    Okyay K; Cengel A; Sahinarslan A; Tavil Y; Turkoglu S; Biberoglu G; Hasanoglu A
    Coron Artery Dis; 2007 Nov; 18(7):539-44. PubMed ID: 17925607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention.
    Lu TM; Ding YA; Lin SJ; Lee WS; Tai HC
    Eur Heart J; 2003 Nov; 24(21):1912-9. PubMed ID: 14585249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of plasma asymmetric dimethylarginine, homocysteine, and high-sensitive CRP levels in occult coronary artery disease: A multidetector-row computed tomography study.
    Gürel E; Tigen K; Karaahmet T; Geçmen Ç; Mutlu B; Başaran Y
    Herz; 2015 May; 40(3):495-501. PubMed ID: 24357092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary asymmetric dimethylarginine (ADMA) is a predictor of mortality risk in patients with coronary artery disease.
    Wolf C; Lorenzen JM; Stein S; Tsikas D; Störk S; Weidemann F; Ertl G; Anker SD; Bauersachs J; Thum T
    Int J Cardiol; 2012 May; 156(3):289-94. PubMed ID: 21159392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease.
    Wang J; Sim AS; Wang XL; Salonikas C; Naidoo D; Wilcken DE
    Atherosclerosis; 2006 Feb; 184(2):383-8. PubMed ID: 15939423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between L-arginine/asymmetric dimethylarginine, homocysteine, folic acid, vitamin B levels, and coronary artery ectasia.
    Koc F; Ardic I; Erdem S; Kalay N; Ozbek K; Yarlioglues M; Ceyhan K; Celik A; Kadi H; Taner A; Sahin S; Onalan O; Kaya MG
    Coron Artery Dis; 2010 Dec; 21(8):445-9. PubMed ID: 20861735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.